{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:32:58Z","timestamp":1784169178059,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.humpath.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T15:59:25Z","timestamp":1532015965000},"page":"76-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs"],"prefix":"10.1016","volume":"82","author":[{"given":"Jeffrey","family":"Cloutier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Cimino-Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Rooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.07.011_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary","volume":"95","author":"Pavel","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.humpath.2018.07.011_bb0010","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.humpath.2018.07.011_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.soc.2015.08.010","article-title":"Treatment of neuroendocrine liver metastases","volume":"25","author":"Farley","year":"2016","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.humpath.2018.07.011_bb0020","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s11605-015-2931-z","article-title":"Role of locoregional and systemic approaches for the treatment of patients with metastatic neuroendocrine tumors","volume":"19","author":"Grandhi","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.humpath.2018.07.011_bb0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/030089161109700504","article-title":"Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?","volume":"97","author":"Catena","year":"2011","journal-title":"Tumori"},{"key":"10.1016\/j.humpath.2018.07.011_bb0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00000478-200009000-00006","article-title":"Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients","volume":"24","author":"Shin","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0035","series-title":"World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs","first-page":"32","article-title":"Invasive breast carcinoma, neuroendocrine tumors","author":"Ellis","year":"2003"},{"key":"10.1016\/j.humpath.2018.07.011_bb0040","series-title":"World Health Organization Classification of Tumors of the Breast","first-page":"62","article-title":"Carcinoma with neuroendocrine features","author":"Bussolati","year":"2012"},{"key":"10.1016\/j.humpath.2018.07.011_bb0045","doi-asserted-by":"crossref","first-page":"408459","DOI":"10.1155\/2014\/408459","article-title":"Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma","volume":"2014","author":"Wachter","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.humpath.2018.07.011_bb0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/his.12306","article-title":"Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma","volume":"64","author":"Kwon","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2018.07.011_bb0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2559.2011.03880.x","article-title":"Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges","volume":"59","author":"Tang","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2018.07.011_bb0060","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.humpath.2010.11.014","article-title":"Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation","volume":"42","author":"Tian","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/S0046-8177(03)00411-8","article-title":"Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer","volume":"34","author":"Makretsov","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.semdp.2009.12.003","article-title":"Neuroendocrine differentiation in breast cancer: established facts and unresolved problems","volume":"27","author":"Righi","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/his.12766","article-title":"Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome","volume":"68","author":"Bogina","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2018.07.011_bb0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1634\/theoncologist.2015-0309","article-title":"Neuroendocrine carcinoma of the breast: current evidence and future perspectives","volume":"21","author":"Inno","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.humpath.2018.07.011_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2559.2002.01336.x","article-title":"Neuroendocrine differentiation and prognosis in breast adenocarcinoma","volume":"40","author":"Miremadi","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2018.07.011_bb0090","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/01.pas.0000206220.08232.2d","article-title":"Intraductal spread by metastatic islet cell tumor (well-differentiated pancreatic endocrine neoplasm) involving the breast of a child, mimicking a primary mammary carcinoma","volume":"30","author":"Judson","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0095","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2559.2011.03940.x","article-title":"Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma","volume":"59","author":"Perry","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2018.07.011_bb0100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.humpath.2012.11.003","article-title":"GATA3 expression in breast carcinoma: utility in triple negative, sarcomatoid and metastatic carcinomas","volume":"44","author":"Cimino-Mathews","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3816\/CBC.2007.n.056","article-title":"Breast carcinoma with neuroendocrine differentiation and myocardial metastases","volume":"7","author":"Hennessy","year":"2007","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.humpath.2018.07.011_bb0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1066896916632909","article-title":"Breast carcinoma with unrecognized neuroendocrine differentiation metastasizing to the pancreas: a potential diagnostic pitfall","volume":"24","author":"Christensen","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/dc.20753","article-title":"Synchronous metastases to the liver and pancreas from a primary neuroendocrine carcinoma of the breast diagnosed by fine-needle aspiration","volume":"36","author":"McIntire","year":"2008","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0120","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijscr.2014.05.006","article-title":"Neuroendocrine breast carcinoma metastatic to the liver: report of a case and review of the literature","volume":"5","author":"Manes","year":"2014","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.humpath.2018.07.011_bb0125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.semdp.2015.09.013","article-title":"Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy?","volume":"32","author":"Koo","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAP.0b013e3182a2dc67","article-title":"Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry","volume":"20","author":"Bellizzi","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0135","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/PAS.0000000000000876","article-title":"Immunohistochemical characterization of the origins of metastatic well-differentiated neuroendocrine tumors to the liver","volume":"41","author":"Yang","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.humpath.2006.02.005","article-title":"Carcinoid tumorlets simulate pulmonary metastases in women with breast cancer","volume":"37","author":"Darvishian","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0145","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.5858\/132.12.1889","article-title":"Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors","volume":"132","author":"Sica","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2018.07.011_bb0150","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/1097-0142(19921101)70:9<2268::AID-CNCR2820700910>3.0.CO;2-X","article-title":"Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin","volume":"70","author":"Viale","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2018.07.011_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0160","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1097\/PAS.0b013e31829cdba7","article-title":"GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder","volume":"37","author":"Ellis","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5858\/2008-132-239-AOEPOB","article-title":"Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors","volume":"132","author":"Takeda","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2018.07.011_bb0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/TDP92PQLDE2HLEET","article-title":"Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity","volume":"127","author":"Bhargava","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.07.011_bb0175","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1309\/AJCPMFR6OA8ICHNH","article-title":"Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin","volume":"135","author":"Lewis","year":"2011","journal-title":"Am J Clin Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718302697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718302697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T22:12:21Z","timestamp":1661638341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718302697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"alternative-id":["S0046817718302697"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.07.011","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}